Masimo Co. (NASDAQ:MASI) Director Adam Mikkelson Sells 600 Shares

Masimo Co. (NASDAQ:MASI) Director Adam Mikkelson sold 600 shares of the firm’s stock in a transaction on Monday, January 10th. The shares were sold at an average price of $250.01, for a total transaction of $150,006.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of MASI opened at $233.08 on Friday. The firm has a 50-day moving average of $281.68 and a 200-day moving average of $276.08. Masimo Co. has a one year low of $205.10 and a one year high of $305.21. The company has a market cap of $12.87 billion, a PE ratio of 58.12 and a beta of 0.73.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Monday, October 25th. The medical equipment provider reported $0.94 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.03. Masimo had a net margin of 19.23% and a return on equity of 15.56%. The company had revenue of $307.40 million during the quarter, compared to the consensus estimate of $295.79 million. During the same quarter last year, the firm posted $0.80 EPS. The company’s quarterly revenue was up 10.5% on a year-over-year basis. As a group, analysts expect that Masimo Co. will post 3.88 earnings per share for the current year.

MASI has been the subject of a number of analyst reports. Piper Sandler raised their target price on shares of Masimo from $320.00 to $330.00 and gave the company an “overweight” rating in a research report on Monday, November 15th. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $298.00 target price for the company in a research report on Monday, September 27th. Finally, Raymond James initiated coverage on shares of Masimo in a research report on Tuesday, October 12th. They issued a “market perform” rating for the company.

Several hedge funds and other institutional investors have recently bought and sold shares of MASI. Isthmus Partners LLC acquired a new stake in shares of Masimo during the 2nd quarter worth about $36,000. Fifth Third Bancorp lifted its stake in shares of Masimo by 51.1% during the 3rd quarter. Fifth Third Bancorp now owns 136 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 46 shares during the last quarter. Dupont Capital Management Corp acquired a new stake in shares of Masimo during the 3rd quarter worth about $46,000. Altshuler Shaham Ltd acquired a new stake in shares of Masimo during the 3rd quarter worth about $49,000. Finally, Ibex Wealth Advisors acquired a new stake in shares of Masimo during the 3rd quarter worth about $54,000. Institutional investors own 82.76% of the company’s stock.

About Masimo

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories.

Further Reading: What is Depreciation?

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with's FREE daily email newsletter.